The Role of Oxidative Stress in the Metabolic Syndrome

被引:97
作者
Whaley-Connell, Adam [1 ,2 ]
McCullough, Peter A. [3 ]
Sowers, James R. [1 ,2 ]
机构
[1] Harry S Truman VA Med Ctr, Diabet & Cardiovasc Ctr, Columbia, MO 65201 USA
[2] Univ Missouri, Sch Med, Columbia, MO USA
[3] Providence Pk Hosp, St John Providence Hlth Syst, Dept Med, Cardiol Sect, Novi, MI USA
关键词
Metabolic syndrome; Oxidative stress; Labile iron; Neutrophil-associated lipocalin; Galectin-3; ANGIOTENSIN-ALDOSTERONE SYSTEM; CORONARY-HEART-DISEASE; NITRIC-OXIDE SYNTHASE; INSULIN-RESISTANCE; CARDIOVASCULAR-DISEASE; NAD(P)H OXIDASE; CLINICAL-IMPLICATIONS; INDUCED HYPERTENSION; KIDNEY-DISEASE; NADPH OXIDASES;
D O I
10.3909/ricm0555
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Loss of reduction-oxidation (redox) homeostasis and generation of excess free oxygen radicals play an important role in the pathogenesis of diabetes, hypertension, and consequent cardiovascular disease. Reactive oxygen species are integral in routine in physiologic mechanisms. However, loss of redox homeostasis contributes to proinflammatory and pro fibrotic pathways that promote impairments in insulin metabolic signaling, reduced endothelial-mediated vasorelaxation, and associated cardiovascular and renal structural and functional abnormalities. Redox control of metabolic function is a dynamic process with reversible pro- and anti-free radical processes. Labile iron is necessary for the catalysis of superoxide anion, hydrogen peroxide, and the generation of the damaging hydroxyl radical. Acute hypoxia and cellular damage in cardiovascular tissue liberate larger amounts of cytosolic and extracellular iron that is poorly liganded; thus, large increases in the generation of oxygen free radicals are possible, causing tissue damage. The understanding of iron and the imbalance of redox homeostasis within the vasculature is integral in hypertension and progression of metabolic dysregulation that contributes to insulin resistance, endothelial dysfunction, and cardiovascular and kidney disease. [Rev Cardiovasc Med. 2011;12(1):21-29 doi: 10.3909/ricm0555] (C) 2011 MedReviews (R), LLC
引用
收藏
页码:21 / 29
页数:9
相关论文
共 82 条
[1]   Standards of medical care in diabetes 2008 [J].
不详 .
DIABETES CARE, 2008, 31 :S12-S54
[2]  
Arts ICW, 2005, AM J CLIN NUTR, V81, p317S, DOI 10.1093/ajcn/81.1.317S
[3]   The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology [J].
Bedard, Karen ;
Krause, Karl-Heinz .
PHYSIOLOGICAL REVIEWS, 2007, 87 (01) :245-313
[4]   From kidney to cardiovascular diseases: NGAL as a biomarker beyond the confines of nephrology [J].
Bolignano, D. ;
Coppolino, G. ;
Lacquaniti, A. ;
Buemi, M. .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2010, 40 (03) :273-276
[5]   Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage [J].
Bolignano, Davide ;
Donato, Valentina ;
Coppolino, Giuseppe ;
Campo, Susanna ;
Buemi, Antoine ;
Lacquaniti, Antonio ;
Buemi, Michele .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2008, 52 (03) :595-605
[6]   Interaction of Aldosterone and Extracellular Volume in the Pathogenesis of Obesity-Associated Kidney Disease: A Narrative Review [J].
Bomback, Andrew S. ;
Klemmer, Philip J. .
AMERICAN JOURNAL OF NEPHROLOGY, 2009, 30 (02) :140-146
[7]  
Bosch J, 2006, NEW ENGL J MED, V355, P1551
[8]  
Bravo L, 1998, NUTR REV, V56, P317, DOI 10.1111/j.1753-4887.1998.tb01670.x
[9]   Aldosterone and vascular inflammation [J].
Brown, Nancy J. .
HYPERTENSION, 2008, 51 (02) :161-167
[10]   Are 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors renoprotective? [J].
Campese, VM ;
Nadim, MK ;
Epstein, M .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 :S11-S17